Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls.
BACKGROUND
The exact cause of schizophrenia is not known, although several aetiological theories have been proposed for the disease, including developmental or neurodegenerative processes, neurotransmitter abnormalities, viral infection and immune dysfunction or autoimmune mechanisms. Growing evidence suggests that specific cytokines and chemokines play a role in signalling the brain to produce neurochemical, neuroendocrine, neuroimmune and behavioural changes. A relationship between inflammation and schizophrenia was supported by abnormal cytokines production, abnormal concentrations of cytokines and cytokine receptors in the blood and cerebrospinal fluid in schizophrenia. Since the neuropathology of schizophrenia has recently been reported to be closely associated with microglial activation we aimed to determined whether spontaneous or LPS-induced peripheral blood mononuclear cell chemokines and cytokines production is dysregulated in schizophrenic patients compared to healthy subjects. We enrolled 51 untreated first-episode schizophrenics (SC) and 40 healthy subjects (HC) and the levels of MCP-1, MIP-1α, IL-8, IL-18, IFN-γ and RANTES were determined by Elisa method in cell-free supernatants of PBMC cultures.


RESULTS
In the simultaneous quantification we found significantly higher levels of constitutively and LPS-induced MCP-1, MIP-1α, IL-8 and IL-18, and lower RANTES and IFNγ levels released by PBMC of SC patients compared with HC. In ten SC patients receiving therapy with risperidone, olanzapine or clozapine basal and LPS-induced production of RANTES and IL-18 was increased, while both basal and LPS-induced MCP-1 production was decreased. No statistically significant differences were detected in serum levels after therapy.


CONCLUSIONS
The observation that in schizophrenic patients the PBMC production of selected chemo-cytokines is dysregulated reinforces the hypothesis that the peripheral cyto-chemokine network is involved in the pathophysiology of schizophrenia. These preliminary, but promising data are supportive of the application of wider profiling approaches to the identification of biomarker as diagnostic tools for the analysis of psychiatric diseases.
Department of Oncology and Experimental Medicine, University G, D'Annunzio, Via dei Vestini, 31, Chieti, 66123, Italy. mreale@unich.it
Marcella
M
Reale
Antonia
A
Patruno
Maria A
MA
De Lutiis
Mirko
M
Pesce
Mario
M
Felaco
Massimo
M
Di Giannantonio
Marta
M
Di Nicola
Alfredo
A
Grilli
D000328:Adult; D002478:Cells, Cultured; D018925:Chemokines / Q000096:biosynthesis* / Q000502:physiology; D016207:Cytokines / Q000096:biosynthesis* / Q000502:physiology; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000378:metabolism / Q000473:pathology; D008875:Middle Aged; D012559:Schizophrenia / Q000378:metabolism* / Q000473:pathology
D018925:Chemokines; D016207:Cytokines
Biol Psychiatry. 2008 Apr 15;63(8):801-8
18005941
Med Hypotheses. 2001 Apr;56(4):483-6
11339852
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):710-4
18096286
J Neuroimmunol. 2002 Feb;123(1-2):170-9
11880161
Psychiatry Res. 1994 Jan;51(1):1-10
7910974
Schizophr Res. 2002 Oct 1;57(2-3):247-58
12223256
Curr Opin Pharmacol. 2002 Feb;2(1):63-8
11786310
Am J Psychiatry. 2000 May;157(5):683-94
10784457
Nat Rev Neurosci. 2008 Jan;9(1):46-56
18073775
World J Biol Psychiatry. 2000 Oct;1(4):173-9
12607212
BMC Psychiatry. 2007 Sep 06;7:46
17822540
Psychiatry Res. 2000 Sep 25;96(1):75-80
10980328
Trends Immunol. 2001 Feb;22(2):83-7
11286708
J Leukoc Biol. 2008 Sep;84(3):587-94
18467654
Cytokine Growth Factor Rev. 1996 Jun;7(1):35-46
8864353
Curr Immunol Rev. 2010 Aug;6(3):213-220
21057585
Mini Rev Med Chem. 2009 Sep;9(10):1229-41
19817713
Neuropsychobiology. 1998;37(4):186-93
9648126
Neuropsychobiology. 2002;46(4):169-72
12566931
Brain Behav Immun. 2001 Dec;15(4):340-70
11782103
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Nov;28(7):1129-34
15610925
Mediators Inflamm. 2001 Jun;10(3):109-15
11545247
Biol Psychiatry. 2004 May 15;55(10):965-70
15121478
Schizophr Res. 2001 Jan 15;47(1):13-25
11163541
Schizophr Res. 1996 Jul 5;20(3):269-73
8827853
Mol Psychiatry. 2000 Nov;5(6):594-603
11126390
Brain. 2004 Jul;127(Pt 7):1463-78
15180926
J Alzheimers Dis. 2008 Jun;14(2):147-59
18560127
Nature. 1990 Oct 18;347(6294):669-71
1699135
Brain Behav Immun. 2001 Dec;15(4):319-39
11782102
Psychiatry Res. 1997 Feb 7;66(2-3):145-52
9075278
J Clin Psychiatry. 2004 Jul;65(7):940-7
15291683
Eur Arch Psychiatry Clin Neurosci. 1996;246(5):279-84
8863007
J Leukoc Biol. 2005 Dec;78(6):1204-9
16204637
Neuropsychobiology. 2009;59(2):123-9
19390223
J Neuroimmunol. 1995 Jul;60(1-2):143-50
7642742
Brain Behav Immun. 2006 Nov;20(6):532-45
16580814